Showing results (531-540 of 1,644) with videos related to
Sort By:
Pageof 165
International Journal of Molecular Sciences|December 10, 2021
The Cytokine Mediated Molecular Pathophysiology of Psoriasis and Its Clinical ImplicationsRohan Singh, Sindhuja Koppu, Patrick O Perche, et al.The Journal of Dermatological Treatment|May 20, 2017
Interleukin-17 inhibition: role in psoriasis and inflammatory bowel diseaseMegan Hohenberger, Leah A Cardwell, Elias Oussedik, et al.Journal of the American Academy of Child and Adolescent Psychiatry|June 11, 1999
Neuropsychological factors associated with borderline pathology in childrenJ Paris, P Zelkowitz, J Guzder, et al.Applied Optics|April 10, 1997
Comparison of encoding methods for computer-generated diffractive optical elementsR Hutchins, H Yang, J E Morris, et al.Archives of Dermatology|January 19, 2005
Members of the national psoriasis foundation: more extensive disease and better informed about treatment optionsTamar Nijsten, Tara Rolstad, Steven R Feldman, et al.Journal of Managed Care & Specialty Pharmacy|September 25, 2015
Economic and Comorbidity Burden Among Patients with Moderate-to-Severe PsoriasisSteven R Feldman, Yang Zhao, Lizheng Shi, et al.American Journal of Clinical Dermatology|January 19, 2013
Combination therapy in psoriasis: an evidence-based reviewCheryl J Gustafson, Casey Watkins, Emily Hix, et al.Journal of Drugs in Dermatology : JDD|April 3, 2013
A multicenter, randomized, double-blind study of the efficacy and safety of calcipotriene foam, 0.005%, vs vehicle foam in the treatment of plaque-type psoriasis of the scalpSteven R Feldman, Mary Mills, Thomas Brundage, et al.Dermatology Online Journal|February 23, 2026
Silver sulfadiazine in modern dermatologyNatalia Chalupczak, Jessica Q Duong, Joseph Jorizzo, et al.Dermatology Online Journal|March 25, 2014
Are topical keratolytic agents needed in the treatment of scalp psoriasis?Divya Shokeen, Jenna L O'Neill, Arash Taheri, et al.Pageof 165